For an estimated one in six European couples, trying for a baby proves an often fruitless and frustrating process. Those wanting to avoid invasive techniques like in vitro fertilization (IVF) and opting for a more natural approach may find their lives being taken over by complicated calendar-based calculations or early morning toilet duties. UK-based Cambridge Temperature Concepts has developed a sophisticated body temperature measurement system which helps couples predict the best time to plan for a romantic evening, and is backed by a money-back guarantee. A wireless sensor stuck under the arm continuously monitors the minute changes in basal body temperature indicative of ovulation, and wirelessly sends the results to a hand-held reader which displays a six day optimum conception forecast.
For anyone who has ever experienced or witnessed the debilitating effects of period pain, they’ll be glad to know that the suffering may soon be at an end. Vantia Therapeutics has announced that its new development, an oral small molecule drug for now known simply as VA111913, has entered its second phase of testing as a treatment for dysmenorrhoea (painful menstruation). If results are successful the drug could be available for commercial use within four years.